NM_001366385.1(CARD14):c.1960G>C (p.Val654Leu) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 25, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001295023.7

Allele description [Variation Report for NM_001366385.1(CARD14):c.1960G>C (p.Val654Leu)]

NM_001366385.1(CARD14):c.1960G>C (p.Val654Leu)

Genes:

SGSH:N-sulfoglucosamine sulfohydrolase [Gene - OMIM - HGNC]
CARD14:caspase recruitment domain family member 14 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17q25.3

Genomic location:

Preferred name:

NM_001366385.1(CARD14):c.1960G>C (p.Val654Leu)

HGVS:

NC_000017.11:g.80201852G>C
NG_032778.1:g.36861G>C
NM_001257970.1:c.1960G>C
NM_001366385.1:c.1960G>CMANE SELECT
NM_024110.4:c.1960G>C
NP_001244899.1:p.Val654Leu
NP_001353314.1:p.Val654Leu
NP_077015.2:p.Val654Leu
LRG_1330t1:c.1960G>C
LRG_1330:g.36861G>C
LRG_1330p1:p.Val654Leu
NC_000017.10:g.78175651G>C
NR_047566.2:n.2087G>C

Protein change:

V654L

Links:

dbSNP: rs778539318

NCBI 1000 Genomes Browser:

rs778539318

Molecular consequence:

NM_001257970.1:c.1960G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001366385.1:c.1960G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_024110.4:c.1960G>C - missense variant - [Sequence Ontology: SO:0001583]
NR_047566.2:n.2087G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Pityriasis rubra pilaris (PRP)
Synonyms:: Pityriasis rubra pilaris--familial type
Identifiers:: MONDO: MONDO:0100017; MedGen: C0032027; Orphanet: 2897; OMIM: 173200

Name:: Psoriasis 2
Identifiers:: MONDO: MONDO:0011269; MedGen: C1864497; OMIM: 602723

Recent activity

Clear Turn Off Turn On

Homo sapiens clone E1 LOC642414 pseudogene mRNA, partial sequence
Homo sapiens clone E1 LOC642414 pseudogene mRNA, partial sequence
gi|386118296|gb|JF968459.1|

Nucleotide
Homo sapiens clone C7 LOC643126 pseudogene mRNA, partial sequence
Homo sapiens clone C7 LOC643126 pseudogene mRNA, partial sequence
gi|386118289|gb|JF968455.1|

Nucleotide
PREDICTED: Latimeria chalumnae T-box transcription factor Tb (TBXTB), transcript...
PREDICTED: Latimeria chalumnae T-box transcription factor Tb (TBXTB), transcript variant X3, mRNA
gi|556969133|ref|XM_005993348.1|

Nucleotide
P022BG
P022BG

biosample
Homo sapiens tripartite motif containing 53C, pseudogene (TRIM53CP) on chromosom...
Homo sapiens tripartite motif containing 53C, pseudogene (TRIM53CP) on chromosome 11
gi|426214198|ref|NG_021782.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001483932	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 25, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001483932

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 25, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001483932.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CARD14-related conditions. This variant is present in population databases (rs778539318, ExAC 0.002%). This sequence change replaces valine with leucine at codon 654 of the CARD14 protein (p.Val654Leu). The valine residue is moderately conserved and there is a small physicochemical difference between valine and leucine.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine